Similar articles

• Influence of left ventricular lead location on outcomes in the COMPANION study.

  Saxon LA, Olshansky B, Volosin K, Steinberg JS, Lee BK, Tomassoni G, Guarnieri T, Rao A, Yong P, Galle E, Leigh J, Ecklund F, Bristow MR. Saxon LA, et al. J Cardiovasc Electrophysiol. 2009 Jul;20(7):764-8. doi: 10.1111/j.1540-8167.2009.01444.x. Epub 2009 Feb 27. J Cardiovasc Electrophysiol. 2009. PMID: 19298563
• The Managed Ventricular pacing versus VVI 40 Pacing (MVP) Trial: clinical background, rationale, design, and implementation.

  Sweeney MO, Ellenbogen KA, Miller EH, Sherfesee L, Sheldon T, Whellan D. Sweeney MO, et al. J Cardiovasc Electrophysiol. 2006 Dec;17(12):1295-8. doi: 10.1111/j.1540-8167.2006.00656.x. Epub 2006 Nov 1. J Cardiovasc Electrophysiol. 2006. PMID: 17081208
• Managing with pacemakers and implantable cardioverter defibrillators.

  Lampert R. Lampert R. Circulation. 2013 Oct 1;128(14):1576-85. doi: 10.1161/CIRCULATIONAHA.113.001555. Circulation. 2013. PMID: 24081953 Review. No abstract available.
• Cardiac resynchronization therapy in heart failure patients: an update.

  Jeevanantham V, Daubert JP, Zareba W. Jeevanantham V, et al. Cardiol J. 2009;16(3):197-209. Cardiol J. 2009. PMID: 19437393 Review.
• [Cardiac resynchronization therapy with or without defibrillation backup: everything has been written?].

  Botto GL, Luzi M, Russo G, Mariconti B. Botto GL, et al. G Ital Cardiol (Rome). 2010 Apr;11(4):306-9. G Ital Cardiol (Rome). 2010. PMID: 20677576 Italian. No abstract available.